Steve Tutewohl, Chief Operating Officer at Evolent Health, Inc. (EVH), sold 14,781 shares at $27.41 ($405K) on 2022-03-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $405k EVH by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.40 | 4,005 | $110K | 27.1% |
| 2 | $27.41 | 5,388 | $148K | 36.5% |
| 3 | $27.41 | 5,388 | $148K | 36.5% |
| Total | $27.41 avg | 14,781 | $405K | 100% |
| Filing → |
| EVH | SELL | 2022-02-01 | $296K | — | Filing → |
| EVH | SELL | 2021-09-02 | $679K | — | Filing → |
| EVH | SELL | 2021-08-04 | $1.4M | — | Filing → |